These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 8061081)
1. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. Serpelloni G; Carrieri MP; Rezza G; Morganti S; Gomma M; Binkin N AIDS Care; 1994; 6(2):215-20. PubMed ID: 8061081 [TBL] [Abstract][Full Text] [Related]
2. Psychoeducational group approach: HIV risk reduction in drug users. Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443 [TBL] [Abstract][Full Text] [Related]
3. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group]. Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232 [TBL] [Abstract][Full Text] [Related]
4. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province]. Rittmannsberger H; Ruschak M; Silberbauer C Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337 [TBL] [Abstract][Full Text] [Related]
5. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M; Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278 [TBL] [Abstract][Full Text] [Related]
6. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach. Weiss SH; Weston CB; Quirinale J AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708 [TBL] [Abstract][Full Text] [Related]
7. [Do we need a methadone maintenance program?]. Täschner KL Nervenarzt; 1991 Sep; 62(9):524-8. PubMed ID: 1956471 [No Abstract] [Full Text] [Related]
8. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur. Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497 [TBL] [Abstract][Full Text] [Related]
9. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Hartel DM; Schoenbaum EE Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816 [TBL] [Abstract][Full Text] [Related]
10. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care. Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205 [TBL] [Abstract][Full Text] [Related]
11. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection. Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324 [TBL] [Abstract][Full Text] [Related]
12. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S AIDS Educ Prev; 2007 Apr; 19(2):124-36. PubMed ID: 17411415 [TBL] [Abstract][Full Text] [Related]
13. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance. Stein MD; Urdaneta ME; Clarke J; Maksad J; Sobota M; Hanna L; Markson LE J Addict Dis; 2000; 19(1):85-94. PubMed ID: 10772605 [TBL] [Abstract][Full Text] [Related]
14. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747 [TBL] [Abstract][Full Text] [Related]
15. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. Avants SK; Margolin A; Usubiaga MH; Doebrick C J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083 [TBL] [Abstract][Full Text] [Related]
17. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy. Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA; Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028 [TBL] [Abstract][Full Text] [Related]
18. Out-patient medical care in Edinburgh for IDU-related HIV. Brettle RP; Willocks L; Hamilton BA; Shaw L; Leen CL; Richardson A; Gore SM AIDS Care; 1994; 6(1):49-58. PubMed ID: 8186277 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003. Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K; Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819 [TBL] [Abstract][Full Text] [Related]
20. Knowledge of and interest in hepatitis C treatment at a methadone clinic. Walley AY; White MC; Kushel MB; Song YS; Tulsky JP J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]